The Genetic Variability of in Different Human Populations and Its Implications for Longevity

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2019 Mar 20

PMID 30884759

Citations 68

Authors

Paolo Abondio

Marco Sazzini

Paolo Garagnani

Alessio Boattini

Daniela Monti

Claudio Franceschi

Donata Luiselli

Cristina Giuliani

Affiliations

Soon will be listed here.

Abstract

Human longevity is a complex phenotype resulting from the combinations of context-dependent gene-environment interactions that require analysis as a dynamic process in a cohesive ecological and evolutionary framework. Genome-wide association (GWAS) and whole-genome sequencing (WGS) studies on centenarians pointed toward the inclusion of the apolipoprotein E () polymorphisms ε2 and ε4, as implicated in the attainment of extreme longevity, which refers to their effect in age-related Alzheimer's disease (AD) and cardiovascular disease (CVD). In this case, the available literature on and its involvement in longevity is described according to an anthropological and population genetics perspective. This aims to highlight the evolutionary history of this gene, how its participation in several biological pathways relates to human longevity, and which evolutionary dynamics may have shaped the distribution of haplotypes across the globe. Its potential adaptive role will be described along with implications for the study of longevity in different human groups. This review also presents an updated overview of the worldwide distribution of alleles based on modern day data from public databases and ancient DNA samples retrieved from literature in the attempt to understand the spatial and temporal frame in which present-day patterns of variation evolved.

Citing Articles

Immunogenetics of longevity and its association with human endogenous retrovirus K.

James L, Georgopoulos A Front Aging. 2025; 6:1471202.

PMID: 39967996 PMC: 11832543. DOI: 10.3389/fragi.2025.1471202.

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons.

Hu H, Wan S, Hu Y, Wang Q, Li H, Zhang N Ann Med. 2025; 57(1):2445194.

PMID: 39745195 PMC: 11703089. DOI: 10.1080/07853890.2024.2445194.

AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease mice.

Gunaydin C, Sondhi D, Kaminsky S, Lephart H, Leopold P, Hackett N Mol Ther. 2024; 32(12):4303-4318.

PMID: 39511891 PMC: 11638875. DOI: 10.1016/j.ymthe.2024.11.003.

Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health.

Laslo A, Laslo L, Arbanasi E, Ujlaki-Nagi A, Chinezu L, Ivanescu A Pathophysiology. 2024; 31(4):545-558.

PMID: 39449522 PMC: 11503414. DOI: 10.3390/pathophysiology31040040.

iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta.

Ding Y, Palecek S, Shusta E Fluids Barriers CNS. 2024; 21(1):79.

PMID: 39394110 PMC: 11468049. DOI: 10.1186/s12987-024-00580-2.

References

Nguyen D, Dhanasekaran P, Phillips M, Lund-Katz S . Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry. 2009; 48(13):3025-32. PMC: 2765560. DOI: 10.1021/bi9000694. View

Simon R, Girod M, Fonbonne C, Salvador A, Clement Y, Lanteri P . Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides. Mol Cell Proteomics. 2012; 11(11):1389-403. PMC: 3494189. DOI: 10.1074/mcp.M112.018861. View

Xu Q, Brecht W, Weisgraber K, Mahley R, Huang Y . Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004; 279(24):25511-6. DOI: 10.1074/jbc.M311256200. View

Gondar V, Molina-Jimenez F, Hishiki T, Garcia-Buey L, Koutsoudakis G, Shimotohno K . Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus. J Virol. 2015; 89(19):9962-73. PMC: 4577890. DOI: 10.1128/JVI.00577-15. View

Matsunaga A, Saito T . Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia. Clin Exp Nephrol. 2014; 18(2):220-4. DOI: 10.1007/s10157-013-0918-1. View

Drury J, Narayanaswami V . Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. J Biol Chem. 2005; 280(15):14605-10. DOI: 10.1074/jbc.M414019200. View

McClellan J, King M . Genetic heterogeneity in human disease. Cell. 2010; 141(2):210-7. DOI: 10.1016/j.cell.2010.03.032. View

Cao S, Kaufman R . Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014; 21(3):396-413. PMC: 4076992. DOI: 10.1089/ars.2014.5851. View

Gunther T, Valdiosera C, Malmstrom H, Urena I, Rodriguez-Varela R, Sverrisdottir O . Ancient genomes link early farmers from Atapuerca in Spain to modern-day Basques. Proc Natl Acad Sci U S A. 2015; 112(38):11917-22. PMC: 4586848. DOI: 10.1073/pnas.1509851112. View

10.

Brecht W, Harris F, Chang S, Tesseur I, Yu G, Xu Q . Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004; 24(10):2527-34. PMC: 6729489. DOI: 10.1523/JNEUROSCI.4315-03.2004. View

11.

Yenicesu G, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C . A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2009; 63(2):126-36. DOI: 10.1111/j.1600-0897.2009.00770.x. View

12.

Raber J, Huang Y, Ashford J . ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004; 25(5):641-50. DOI: 10.1016/j.neurobiolaging.2003.12.023. View

13.

Gursky O, Atkinson D . Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci U S A. 1996; 93(7):2991-5. PMC: 39748. DOI: 10.1073/pnas.93.7.2991. View

14.

Wetterau J, Aggerbeck L, Rall Jr S, Weisgraber K . Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem. 1988; 263(13):6240-8. View

15.

Saito H, Dhanasekaran P, Baldwin F, Weisgraber K, Lund-Katz S, Phillips M . Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. J Biol Chem. 2001; 276(44):40949-54. DOI: 10.1074/jbc.M106337200. View

16.

Nakamura T, Watanabe A, Fujino T, Hosono T, Michikawa M . Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol Neurodegener. 2009; 4:35. PMC: 2739857. DOI: 10.1186/1750-1326-4-35. View

17.

Nguyen D, Dhanasekaran P, Nickel M, Nakatani R, Saito H, Phillips M . Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry. 2010; 49(51):10881-9. PMC: 3025481. DOI: 10.1021/bi1017655. View

18.

Tedla N, Glaros E, Brunk U, Jessup W, Garner B . Heterogeneous expression of apolipoprotein-E by human macrophages. Immunology. 2004; 113(3):338-47. PMC: 1782582. DOI: 10.1111/j.1365-2567.2004.01972.x. View

19.

Cashdan E . Biogeography of human infectious diseases: a global historical analysis. PLoS One. 2014; 9(10):e106752. PMC: 4182673. DOI: 10.1371/journal.pone.0106752. View

20.

Garatachea N, Marin P, Santos-Lozano A, Sanchis-Gomar F, Emanuele E, Lucia A . The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis. Rejuvenation Res. 2014; 18(1):3-13. DOI: 10.1089/rej.2014.1605. View